Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience

Am J Hematol. 2018 May;93(5):E123-E125. doi: 10.1002/ajh.25063. Epub 2018 Feb 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antifungal Agents / therapeutic use
  • Drug Therapy, Combination / methods
  • Female
  • Humans
  • Lymphohistiocytosis, Hemophagocytic / drug therapy*
  • Pyrazoles / therapeutic use*

Substances

  • Antifungal Agents
  • INCB018424
  • Pyrazoles